An assessment of thiethylperazine (cas 1420-55-9) (Torecan) in the control of radiation-induced nausea and vomiting
-
Add time:09/29/2019 Source:sciencedirect.com
A double-blind trial was undertaken to compare thiethylperazine (cas 1420-55-9) (Torecan) and pyridoxine as anti-emetics in patients undergoing externally applied radiotherapy to the abdomen and pelvis. The patients who received thiethylperazine experienced fewer or much milder symptoms than those given pyridoxine.
We also recommend Trading Suppliers and Manufacturers of thiethylperazine (cas 1420-55-9). Pls Click Website Link as below: cas 1420-55-9 suppliers
Prev:The prevention of emesis with thiethylperazine (cas 1420-55-9) following oral surgery☆
Next:ClinicalEFFICACY OF thiethylperazine (cas 1420-55-9) AS A RECOVERY ROOM ANTI-EMETIC) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- ClinicalEFFICACY OF thiethylperazine (cas 1420-55-9) AS A RECOVERY ROOM ANTI-EMETIC09/30/2019
- The prevention of emesis with thiethylperazine (cas 1420-55-9) following oral surgery☆09/28/2019
- The metabolism of thiethylperazine (cas 1420-55-9) (torecan®)10/01/2019
- A comparative study of the effects of cinnarizine, sulpiride and thiethylperazine (cas 1420-55-9) on vestibular nystagmus in rabbits09/27/2019
- Dystonic reactions following thiethylperazine (cas 1420-55-9) in children09/26/2019
- Case–control study of teratogenic potential of thiethylperazine (cas 1420-55-9), an anti-emetic drug09/25/2019
- thiethylperazine (cas 1420-55-9)09/24/2019